Mitchell E. Levinson - May 25, 2023 Form 4/A - Amendment Insider Report for Pulse Biosciences, Inc. (PLSE)

Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Stock symbol
PLSE
Transactions as of
May 25, 2023
Transactions value $
$24,965
Form type
4/A - Amendment
Date filed
7/6/2023, 08:32 PM
Date Of Original Report
Jun 13, 2023
Previous filing
May 9, 2023
Next filing
Jul 14, 2023

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Warrant (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -10.9K -100% $0.00* 0 May 25, 2023 Common Stock 10.9K $2.05 Direct
transaction PLSE Warrant (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -814 -100% $0.00* 0 May 25, 2023 Common Stock 814 $2.05 Spouse
transaction PLSE Warrant (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -143 -100% $0.00* 0 May 25, 2023 Common Stock 143 $2.05 Immediate family member
transaction PLSE Warrant (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -143 -100% $0.00* 0 May 25, 2023 Common Stock 143 $2.05 Immediate family member
transaction PLSE Warrant (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -143 -100% $0.00* 0 May 25, 2023 Common Stock 143 $2.05 Immediate family member
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of shares beneficially owned, as reported on the Form 4 filed on June 13, 2023, erroneously included options held by the Reporting Person.